Prime Medicine, The Next Gen Gene Editing Startup Raises $315 Million

Prime Medicine, a biotech startup working on a new approach to gene editing, has officially pulled back the curtain on the progress it has made since beginning operations last summer. The company “launched” on Tuesday, revealing it’s raised $315 million in short order from a large group of well-known biotech backers, including Arch Venture Partners,…